These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19949774)

  • 1. Analysis of potential genotoxic impurities in pharmaceuticals by two-dimensional gas chromatography with Deans switching and independent column temperature control using a low-thermal-mass oven module.
    David F; Jacq K; Sandra P; Baker A; Klee MS
    Anal Bioanal Chem; 2010 Feb; 396(3):1291-300. PubMed ID: 19949774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dimensional gas chromatography with heart-cutting for isotope ratio mass spectrometry analysis of steroids in doping control.
    Brailsford AD; Gavrilović I; Ansell RJ; Cowan DA; Kicman AT
    Drug Test Anal; 2012 Dec; 4(12):962-9. PubMed ID: 22761127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs).
    Elder DP; Lipczynski AM; Teasdale A
    J Pharm Biomed Anal; 2008 Nov; 48(3):497-507. PubMed ID: 18657926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impurity analysis of pure aldrin using heart-cut multi-dimensional gas chromatography-mass spectrometry.
    Li X; Dai X; Yin X; Li M; Zhao Y; Zhou J; Huang T; Li H
    J Chromatogr A; 2013 Feb; 1277():69-75. PubMed ID: 23332869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and sensitive method to analyze genotoxic impurity hydrazine in pharmaceutical materials.
    Wang J; Yang S; Zhang K
    J Pharm Biomed Anal; 2016 Jul; 126():141-7. PubMed ID: 27208624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development.
    Iliou K; Malenović A; Loukas YL; Dotsikas Y
    J Pharm Biomed Anal; 2018 Feb; 149():410-418. PubMed ID: 29154196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances.
    An J; Sun M; Bai L; Chen T; Liu DQ; Kord A
    J Pharm Biomed Anal; 2008 Nov; 48(3):1006-10. PubMed ID: 18687555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A generic approach for the determination of trace hydrazine in drug substances using in situ derivatization-headspace GC-MS.
    Sun M; Bai L; Liu DQ
    J Pharm Biomed Anal; 2009 Feb; 49(2):529-33. PubMed ID: 19097722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate.
    García A; Rupérez FJ; Ceppa F; Pellati F; Barbas C
    J Pharm Biomed Anal; 2012 Mar; 61():230-6. PubMed ID: 22226040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a sensitive GC-MS method for the determination of alkylating agent, 4-chloro-1-butanol, in active pharmaceutical ingredients.
    Harigaya K; Yamada H; Yaku K; Nishi H; Haginaka J
    Chem Pharm Bull (Tokyo); 2014; 62(4):395-8. PubMed ID: 24695350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective determination of potential impurities in an active pharmaceutical ingredient using HPLC-SPE-HPLC.
    Yamamoto E; Niijima J; Asakawa N
    J Pharm Biomed Anal; 2013 Oct; 84():41-7. PubMed ID: 23806999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of residual solvents in pharmaceuticals by thermal desorption-GC/MS.
    Hashimoto K; Urakami K; Fujiwara Y; Terada S; Watanabe C
    Anal Sci; 2001 May; 17(5):645-8. PubMed ID: 11708147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new liquid chromatography-mass spectrometry approach for generic screening and quantitation of potential genotoxic alkylation compounds without derivatization.
    Cappiello A; Famiglini G; Palma P; Termopoli V; Trufelli H
    J Chromatogr A; 2012 Sep; 1255():286-90. PubMed ID: 22226454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of arylamines and aminopyridines in pharmaceutical products using in-situ derivatization and liquid chromatography-mass spectrometry.
    Vanhoenacker G; Dumont E; David F; Baker A; Sandra P
    J Chromatogr A; 2009 Apr; 1216(16):3563-70. PubMed ID: 18804773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach for generic screening and quantitation of potential genotoxic alkylation compounds by pre-column derivatization and LC-MS/MS analysis.
    van Wijk AM; Beerman B; Niederländer HA; Siebum AH; de Jong GJ
    Anal Bioanal Chem; 2011 May; 400(5):1375-85. PubMed ID: 21445660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full evaporation dynamic headspace in combination with selectable one-dimensional/two-dimensional gas chromatography-mass spectrometry for the determination of suspected fragrance allergens in cosmetic products.
    Devos C; Ochiai N; Sasamoto K; Sandra P; David F
    J Chromatogr A; 2012 Sep; 1255():207-15. PubMed ID: 22342208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical Method Development for 19 Alkyl Halides as Potential Genotoxic Impurities by Analytical Quality by Design.
    Lee K; Yoo W; Jeong JH
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process.
    Liu DQ; Chen TK; McGuire MA; Kord AS
    J Pharm Biomed Anal; 2009 Sep; 50(2):144-50. PubMed ID: 19427156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance.
    Vijaya Bhaskar Reddy A; Venugopal N; Madhavi G; Gangadhara Reddy K; Madhavi V
    J Pharm Biomed Anal; 2013 Oct; 84():84-9. PubMed ID: 23816589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.